While the study's findings of this study are worrying, peopleAfrica shouldisn’t avoidmanufacturing fromsubpar makingor sweepingcounterfeit generalizations based on this alonemedicines. ThereCountries areoutside someof possible biases in the researchcontinent, methodssuch includingas non-randomChina sampling and unpublished surveys that found no issuesIndia, asare wellthe asproducers aand lacksuppliers of studiesfake inmedicines. generalThis aboutis substandarda medicationglobal apartpublic fromhealth Asia and Africa. Additionallycrisis, the prevalence of false and subparasking medicationonly fluctuatesAfrican acrossstakeholders time,to countries,fix andthis typeproblem ofis medicationunfair.
UrgentThis actionstudy needsraises to be taken to combat the issuealarm ofover subpara andpublic falsifiedhealth medicinescrisis inthat Africa.could Abe plethoracontributing of factors lead to the prevalencedeaths of thesecountless harmfulpatients medicationsin acrosslow- the continent, and hundredsmiddle-income ofcountries. thousandsBesides ofincreasing peoplepublic haveawareness, diedthe andstakeholders continuemust tostrengthen diesupply aschains aand result.improve Theselogistical incorrectissues medicationsto leadprevent, todetect, ineffective and preventablerespond deaths.to Thesubstandard timeand tofalsified act is nowmedicines.